Rodolfo Pinto Almazán | Neuropharmacology | Best Researcher Award

Posted on by ScienceFather

Dr. Rodolfo Pinto Almazán | Neuropharmacology | Best Researcher Award

Dr. Rodolfo Pinto Almazán, Escuela Superior de Medicina, IPN, Mexico

Dr. Rodolfo Pinto Almazán is a prominent researcher and professor specializing in biomedical sciences and pharmacology. Currently a Level II member of the National System of Researchers (SNI) and a professor at the Instituto Politécnico Nacional (IPN), Mexico, he has made significant contributions to metabolic and neurodegenerative disease research. With a postdoctoral fellowship at USC and Children’s Hospital Los Angeles, Dr. Pinto has authored groundbreaking studies on oxidative stress and brain function. His honors include the Best Research Manuscript Award (2023) and multiple accolades for his impactful research. 📚🔬👨‍🔬🎓

Publication Profile

Scopus

Research Experience and Achievements

Dr. Rodolfo Pinto Almazán is a distinguished researcher with extensive experience in biomedical sciences. He has been a member of the National System of Researchers (SNI) since 2016, currently at Level II. Dr. Pinto is a professor at the Instituto Politécnico Nacional (IPN) and has worked in various prestigious roles, including postdoctoral research at the University of Southern California (USC) and Children’s Hospital Los Angeles. He has contributed significantly to the study of metabolic and neurodegenerative diseases. His career includes multiple research fellowships and awards. 📚🔬🎓👨‍🔬

Educational Background

Dr. Rodolfo Pinto Almazán holds a distinguished academic background in biomedical sciences. He completed his postdoctoral fellowship at the Keck School of Medicine, USC, and Children’s Hospital Los Angeles (2016–2017), studying sex differences in the central nervous system due to early-life stress. He earned his Ph.D. in Biomedical Sciences from the National Autonomous University of Mexico (UNAM) in 2014, focusing on oxidative stress in the hippocampus. Dr. Pinto also holds a Master’s degree in Pharmacology from the Instituto Politécnico Nacional (IPN), where he studied tau protein activation. His Bachelor’s degree in Pharmaceutical Chemistry was awarded by La Salle University, Mexico. 🎓🔬📚👨‍🔬

Technical Experience

Dr. Rodolfo Pinto Almazán possesses extensive technical expertise in histological and molecular techniques. He is skilled in cryosectioning, immunohistochemistry, and cellular staining. His molecular techniques include DNA/RNA extraction, PCR, ELISA, and Western Blot. Dr. Pinto is proficient with laboratory equipment such as HPLC, NanoDrop, cryostats, thermal cyclers, histoquinescence, and both confocal and optical microscopes. He has hands-on experience with animal handling, including injections, surgeries, ovariectomies, and behavioral tests like the Plus Maze and Morris Water Maze. He also excels in laboratory management, overseeing training, budgeting, and protocol optimization. 🧪🔬🧑‍🔬🐁💻

Teaching Experience

Dr. Rodolfo Pinto Almazán has extensive teaching experience across various levels. He served as an invited professor for the “Molecular Bases of Neurological Diseases” course in the Doctoral program in Biomedical Sciences at UNAM in 2017. He has also taught multiple courses in the Master’s program in Health Sciences at the Escuela Superior de Medicina (ESM, IPN) including Clinical Research, Bioethics, and Biostatistics. In addition, Dr. Pinto has taught Medical Residency courses in Pharmacology, Biochemistry, and Research Methodology at institutions like HRAEI, UAEH, and IMSS. His undergraduate teaching spans subjects like Biochemistry, Cellular Biology, and Pharmacology at UVM, demonstrating his wide-ranging expertise in medical and health sciences education. 📚🧑‍🏫💉

Research Focus

Dr. Rodolfo Pinto Almazán’s research focuses primarily on medical mycology, neuroprotection, and metabolic health. His work explores the neuroprotective effects of sex steroids in spinal cord injury, the virulence factors of fungi like Microsporum canis and Nakaseomyces glabratus, and their association with various skin diseases. Additionally, his research includes investigating metabolic disorders, inflammation, and the effects of omega-3 fatty acids in COVID-19 patients. His contributions span topics such as trauma, fungal infections, and neurodegenerative conditions, emphasizing the importance of therapeutic interventions. 🔬🧠🦠🧑‍🔬

Publication Top Notes 

  • Effect of Chronic Tibolone Administration on Memory and Choline Acetyltransferase and Tryptophan Hydroxylase Content in Aging Mice – Castillo-Mendieta, T., Bautista-Poblet, G., Coyoy-Salgado, A., Neri-Gómez, T., Guerra-Araiza, C. (2024) 🧠📚 – 0 citations
  • Mortality-Associated Factors in a Traumatic Brain Injury Population in Mexico – Martínez-Herrera, E., Galindo-Oseguera, E., Castillo-Cruz, J., Arellano-Ramírez, A., Pinto-Almazán, R. (2024) ⚠️💀 – 0 citations
  • Evaluating Sex Steroid Hormone Neuroprotection in Spinal Cord Injury in Animal Models: Is It Promising in the Clinic? – Coyoy-Salgado, A., Segura-Uribe, J., Salgado-Ceballos, H., Moralí de la Brena, G., Guerra-Araiza, C. (2024) 🧠💉 – 0 citations
  • Cutaneous Fusarium Disease and Leukaemias: A Systematic Review – Cortés-López, P.N., Guzmán-Montijo, E., Fuentes-Venado, C.E., Pinto-Almazán, R., Martínez-Herrera, E. (2024) 🦠🩺 – 0 citations
  • Fungal Melanonychia: A Systematic Review – Rodríguez-Cerdeira, C., Martínez-Herrera, E., Cortés-López, P.N., Vega-Sánchez, D.C., Pinto-Almazán, R. (2024) 🦠💅 – 2 citations
  • Remarkable Phenotypic Virulence Factors of Microsporum canis and Their Associated Genes: A Systematic Review – Vite-Garín, T., Estrada-Cruz, N.A., Hernández-Castro, R., Martínez-Herrera, E., Pinto-Almazán, R. (2024) 🦠💪 – 4 citations
  • Virulence and Resistance Factors of Nakaseomyces glabratus (formerly known as Candida glabrata) in Europe: A Systematic Review – Rodríguez-Cerdeira, C., Pinto-Almazán, R., Saunte, D.M.L., Prohic, A., Martínez-Herrera, E. (2024) 🦠🔬 – 1 citation
  • Effectiveness of Omega-3 Fatty Acid Supplementation in Improving the Metabolic and Inflammatory Profiles of Mexican Adults Hospitalized with COVID-19 – Rodríguez-Vera, D., Salazar, J.R., Soriano-Ursúa, M.A., Loza-Mejía, M.A., Pinto-Almazán, R. (2024) 🐟💪 – 1 citation
  • In Silico and In Vivo Evaluation of the Maqui Berry (Aristotelia chilensis (Mol.) Stuntz) on Biochemical Parameters and Oxidative Stress Markers in a Metabolic Syndrome Model – Castillo-García, E.L., Cossio-Ramírez, A.L., Córdoba-Méndez, Ó.A., Gallardo, J.M., Guerra-Araiza, C. (2023) 🍇⚖️ – 0 citations
  • Main Phenotypic Virulence Factors Identified in Trichophyton Rubrum – Martínez-Herrera, E., Moreno-Coutiño, G., Fuentes-Venado, C.E., Pinto-Almazán, R., Rodríguez-Cerdeira, C. (2023) 🦠🦶 – 3 citations

Shubham Sharma | Pharmacology | Best Researcher Award

Posted on by ScienceFather

Shubham Sharma | Pharmacology | Best Researcher Award

Dr Shubham Sharma, Pfizer, United States

Dr. Shubham Sharma is a leading computational modeler with 8+ years of expertise in theoretical materials science, physics, and chemistry. Holding a Ph.D. in Chemical & Environmental Engineering from Brown University (2021), he specializes in atomistic modeling and solid-form design, notably working at Pfizer where he leads drug de-risking efforts. His research in catalysis, electrochemistry, and crystal structure predictions has earned him over 10 Pfizer Bravo awards. Dr. Sharma’s groundbreaking work is recognized globally, including invited talks at major conferences, advancing both pharmaceutical and renewable energy applications. 💻🔬💊⚡

Publication Profile

Google Scholar

Education

This individual holds a PhD in Chemical & Environmental Engineering from Brown University, USA (2016-2021) 🎓, where they conducted research under the guidance of Andrew A. Peterson 🧑‍🔬. Their academic journey began with a Bachelor of Technology (B. Tech) in Chemical Engineering from the Heritage Institute of Technology, India (2012-2016) 🛠️. With a strong foundation in chemical engineering, they have pursued advanced studies focusing on environmental solutions and sustainability 🌍. Their education showcases a dedication to addressing global environmental challenges through innovative engineering approaches and cutting-edge research 🌱📘.

Work Experience

Currently serving as a Senior Scientist in Computational Materials Science at Pfizer Inc. (July 2022 – present) 🧑‍🔬, this individual leads the Solid Form Design Center (SFDC) focused on de-risking potential drug molecules through advanced statistical and quantum mechanical modeling 💊. They contributed to the success of Zavegepant (Zavzpret™) and Rimegepant (Nurtec™) 🌟. As a core member of the Crystal Structure Prediction team, they specialize in electronic structure theory, density functional theory, and atomistic modeling 🧬. They also collaborate with global industrial and academic partners, lead multiple research proposals, and mentor colleagues in computational science 🔬💻.

Selected conference presentations

Sharma has delivered numerous invited talks and presentations globally 🌍. In 2024, they presented on multi-polymorphic systems at the Crystal Form Consortium Symposium (UK) and computational strategies in pharmaceutical research at UConn (US) and IISER (India) 🧪. Sharma also discussed electrocatalysis at the 8th Global Webinar on Materials Science & Engineering in 2023 🧑‍🏫. Other notable presentations include de-risking medicines at AAPS NERDG (2024) and several studies on oxygen reduction reactions and catalytic properties at AIChE, NECS, ECS, and MRS conferences 🎤. Their work spans computational modeling and applied research in materials science and electrocatalysis ⚛️.

Research Focus

The research focus of Sharma spans electrochemistry, catalysis, and materials science. Sharma investigates the design and stability of catalysts, particularly Pt-based and CoPt alloys, for fuel cells and oxygen reduction reactions (ORR) ⚡️🔋. His work includes dynamic stability, reaction barriers, and potential-controlled reactions, using advanced techniques like density functional theory (DFT) and experimental-theoretical integration. He also explores solid form derisking in pharmaceuticals 💊 and carbon electrodes in redox flow batteries. Sharma’s studies contribute to cleaner energy and advanced catalytic systems 🌍🔬, emphasizing electrochemical stability and performance improvement in energy devices.

 

Publication Top Notes

Hard-magnet L10-CoPt nanoparticles advance fuel cell catalysis

Anisotropic Strain Tuning of L10 Ternary Nanoparticles for Oxygen Reduction

Face-centered tetragonal (FCT) Fe and Co alloys of Pt as catalysts for the oxygen reduction reaction (ORR): A DFT study

Ordered CoPt oxygen reduction catalyst with high performance and durability

Metal dissolution from first principles: Potential-dependent kinetics and charge transfer

Assessment of carbon monoxide exposure in roadside food-vending shanties using coal cookstoves in Kolkata, India

Dynamic stability of Pt-based alloys for fuel-cell catalysts calculated from atomistics

Conclusion

Dr. Shubham Sharma’s innovative research in computational modeling and materials science, alongside his leadership in both academic and industrial collaborations, makes him an exceptional candidate for the Best Researcher Award. His contributions have not only advanced pharmaceutical drug design but also impacted renewable energy research, marking him as a distinguished leader in his field.

Patricia Rijo |Pharmacology, Toxicology | Best Researcher Award

Posted on by ScienceFather

Assoc Prof Dr. Patricia Rijo |Pharmacology, Toxicology | Best Researcher Award

Assoc Prof Dr, Patricia Rijo, Universidade Lusófona, Portugal

Assoc Prof Dr. Patricia Rijo is a distinguished academic at Universidade Lusófona in Portugal. With expertise in [mention her field or area of specialization], Dr. Rijo has contributed significantly to [mention any notable contributions or achievements, such as research, publications, or projects]. Her dedication to [mention any relevant causes or academic interests] underscores her commitment to advancing knowledge in her field. Dr. Rijo’s academic leadership and mentorship inspire both colleagues and students alike at Universidade Lusófona.

Publication profile

Scopus

Education

PhD in Pharmacy (specialty in Medicinal Chemistry and Therapeutics) with Distinction, Faculdade de Farmácia da Universidade de Lisboa, 2003.,Master’s Degree (MSc) in Medicinal Chemistry, Faculdade de Farmácia da Universidade de Lisboa, 2003.,Bachelor’s Degree in Chemistry, Faculdade de Ciências da Universidade de Lisboa, 1999.

Professional Experience

Dr. Hyunsook Lee has had a distinguished professional career in academia and research 👩‍🔬. She began as a Research Scientist at Mogam Biotech Research Institute in Korea (1992. Mar – 1994. May) 🔬 and was promoted to Senior Research Scientist (1994. May – 1996. Aug) 🧬. She then transitioned to academia as a Research Assistant Professor at Ewha Womans University (2002. Sept – 2003) 🧪. In 2004, she joined the Dept. of Biological Sciences at Seoul National University (SNU) as an Assistant Professor 📚, advancing to Associate Professor in 2008 and earning early tenure in 2010 🌟. By 2012, she became a full Professor at SNU 🌍. Dr. Lee has also served in several key administrative roles, including Vice Dean of Planning for the College of Natural Sciences (2015 July – 2017 June) 📅, and Dean for Research Affairs at SNU (2021. Feb – 2023. Feb) 🎓. She has been the Head of the AI-Bio Research Center since 2023 🧠🔬 and co-founded Next & Bio in 2019, which later merged with Kolmar Holdings in 2022 💼. Her visiting scientist positions include stints at the Dana Farber Cancer Institute (2010. Aug – 2011. July) 🧬 and Samsung Advanced Institute of Technology (2020. Aug – 2021. Feb) 🏥.

Academic Positions:

Associate Professor at Universidade Lusófona de Humanidades e Tecnologias (ULHT), since June 2020.,Assistant Professor at ULHT (2011-2020).,Coordinator Professor at Escola Superior de Ciências da Saúde (2011-2016).,Assistant at ULHT (2005-2010).,Invited Assistant Professor at Escola Superior de Saúde Ribeiro Sanches (2002-2011).,Monitor at Faculdade de Farmácia da Universidade de Lisboa (2001-2005).

Awards and Honors:

Egon Stahl-Award in Bronze from Society for Medicinal Plant and Natural Product Research (2022).,Various awards for scientific presentations and research contributions.

Additional Skills and Activities:

  • Languages: Proficiency in Portuguese (C2), English (B2), Spanish (B1), French (A2).
  • Supervision: Supervised numerous PhD and Master’s students.
  • Project Leadership: Participation and leadership in multiple research projects.

Publications:

  • Anticancer diterpenes of African natural products: Mechanistic pathways and preclinical developments
    • Authors: Bangay, G., Brauning, F.Z., Rosatella, A., Efferth, T., Rijo, P.
    • Journal: Phytomedicine, 2024, 129, 155634
    • Abstract: This article likely discusses the mechanistic pathways through which diterpenes from African natural products exhibit anticancer properties, as well as their development in preclinical studies.
  • Glycyrrhizic Acid Nanoparticles Subside the Activity of Methicillin-Resistant Staphylococcus aureus by Suppressing PBP2a
    • Authors: Rijo, P., Abuamara, T.M.M., Ali Lashin, L.S., Abd El Maksoud, A.I., Hassan, A.
    • Journal: Pharmaceuticals, 2024, 17(5), 589
    • Abstract: This article likely explores the use of glycyrrhizic acid nanoparticles to combat methicillin-resistant Staphylococcus aureus (MRSA) by targeting the penicillin-binding protein PBP2a.
  • Halimane Derivatives from Plectranthus ornatus Codd. as Novel Anti-cancer Agents
    • Authors: Bangay, G., Brauning, F.Z., Kowalczyk, T., Sitarek, P., Rijo, P.
    • Journal: Biomedicine and Pharmacotherapy, 2024, 174, 116516
    • Abstract: This article likely investigates the anticancer potential of halimane derivatives from Plectranthus ornatus.
  • Solving the antibacterial resistance in Europe: The multipronged approach of the COST Action CA21145 EURESTOP
    • Authors: Seguin-Devaux, C., Mestrovic, T., Arts, J.J., Rijo, P., Mori, M.
    • Journal: Drug Resistance Updates, 2024, 74, 101069
    • Abstract: This editorial likely outlines the efforts and strategies of the COST Action CA21145 EURESTOP in addressing antibacterial resistance in Europe.
  • Biological Activity of 6,7-Dehydroxyroyleanone and Derivatives Obtained from Plectranthus aliciae (Codd) A.J.Paton
    • Authors: Filipe, M.S., Domínguez-Martín, E.M., Pires, T.C.S.P., Barros, L., Rijo, P.
    • Journal: ACS Omega, 2024, 9(16), pp. 18113–18118
    • Abstract: This article likely details the biological activities of 6,7-dehydroxyroyleanone and its derivatives sourced from Plectranthus aliciae.
  • Exploring the Anticancer Potential of Semisynthetic Derivatives of 7α-Acetoxy-6β-hydroxyroyleanone from Plectranthus sp.: An In Silico Approach
    • Authors: Merecz-Sadowska, A., Isca, V.M.S., Sitarek, P., Rijo, P., Zajdel, R.
    • Journal: International Journal of Molecular Sciences, 2024, 25(8)
    • Abstract: This article likely explores the anticancer potential of semisynthetic derivatives of a specific compound from Plectranthus species using computational methods.
  • Anticancer Effects of Abietane Diterpene 7α-Acetoxy-6β-hydroxyroyleanone from Plectranthus grandidentatus and Its Semi-Synthetic Analogs: An In Silico Computational Approach
    • Authors: Isca, V.M.S., Sitarek, P., Merecz-Sadowska, A., Rijo, P., Kowalczyk, T.
    • Journal: Molecules, 2024, 29(8), 1807
    • Abstract: This article likely investigates the anticancer effects of abietane diterpene and its analogs from Plectranthus grandidentatus using computational techniques.
  • Antibiotic Coordination Frameworks against Antibiotic Resistance: How to Involve Students through Experimental Practices in the Search for Solutions to Public Health Problems
    • Authors: Domínguez-Martín, E.M., Ntungwe, E., Isca, V.M.S., André, V., Rijo, P.
    • Journal: Journal of Chemical Education, 2024, 101(5), pp. 2045–2051
    • Abstract: This article likely discusses educational strategies to involve students in experimental practices to address antibiotic resistance.
  • The Precious Potential of the Sacred Tree Chamaecyparis obtusa (Siebold & Zucc.) Endl. as a Source of Secondary Metabolites with Broad Biological Applications
    • Authors: Górski, K.M., Kowalczyk, T., Picot, L., Ghorbanpour, M., Sitarek, P.
    • Journal: International Journal of Molecular Sciences, 2024, 25(5), 2723
    • Abstract: This review likely highlights the various biological applications of secondary metabolites derived from Chamaecyparis obtusa.
  • Enhancement of Vitamin C’s Protective Effect against Thimerosal-Induced Neurotoxicity in the Cerebral Cortex of Wistar Albino Rats: An In Vivo and Computational Study
    • Authors: Hassan, A., Mohsen, R., Rezk, A., Abd El Maksoud, A.I., Mohamed, A.F.
    • Journal: ACS Omega, 2024, 9(8), pp. 8973–8984
    • Abstract: This article likely explores the neuroprotective effects of vitamin C against thimerosal-induced toxicity using both in vivo and computational methods.